Is a New Immune Response Mediator in the NF-κB pathway - SUMO-4 - Related to Type 1 Diabetes?

Eitemau Tebyg

• Expanding NFκB and SUMO ties
  gan: Lee, Moon-Hee, et al.
  Cyhoeddwyd: (2011)
• At the crossroads of SUMO and NF-κB
  gan: Kracklauer, Martin P, et al.
  Cyhoeddwyd: (2003)
• Ubiquitin-mediated NFκB degradation pathway
  gan: Xu, Huimin, et al.
  Cyhoeddwyd: (2015)
• Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway
  gan: Zhu, Liping, et al.
  Cyhoeddwyd: (2018)
• Replenishing Peripheral CD4(+) Regulatory T Cells: A Possible Immune-Intervention Strategy in Type 1 Diabetes?
  gan: Sia, Charles
  Cyhoeddwyd: (2006)